Related references
Note: Only part of the references are listed.NKp30-A prospective target for new cancer immunotherapy strategies
Pedro F. Pinheiro et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications
Simona Sivori et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Targeting natural killer cells in solid tumors
Guillaume Habif et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Targeting PVR (CD155) and its receptors in anti-tumor therapy
Paola Kucan Brlic et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy
Kushal Prajapati et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Management of patients with acute promyelocytic leukemia
Sabine Kayser et al.
LEUKEMIA (2018)
Expression of B7-H6 expression in human hepatocellular carcinoma and its clinical significance
Lujun Chen et al.
CANCER CELL INTERNATIONAL (2018)
Reprogramming acute myeloid leukemia into sensitivity for retinoic-acid-driven differentiation
Noortje van Gils et al.
EXPERIMENTAL HEMATOLOGY (2017)
Retinoic Acid and Immune Homeostasis: A Balancing Act
Martje N. Erkelens et al.
TRENDS IN IMMUNOLOGY (2017)
Clinical significance of novel costimulatory molecule B7-H6 in human breast cancer
Jing Sun et al.
ONCOLOGY LETTERS (2017)
Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients
Ugo Testa et al.
ANNALS OF HEMATOLOGY (2016)
The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells
Sonja Textor et al.
ONCOIMMUNOLOGY (2016)
Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6
Guoshuai Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Retinoic acid receptors: From molecular mechanisms to cancer therapy
Alessandra di Masi et al.
MOLECULAR ASPECTS OF MEDICINE (2015)
Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients
Michaela Semeraro et al.
Science Translational Medicine (2015)
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape
Silvia Pesce et al.
ONCOIMMUNOLOGY (2015)
Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions
Jessica Matta et al.
BLOOD (2013)
Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells
Nathalie Fiegler et al.
BLOOD (2013)
NK cell-based immunotherapy for malignant diseases
Min Cheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Mimicking an Induced Self Phenotype by Coating Lymphomas with the NKp30 Ligand B7-H6 Promotes NK Cell Cytotoxicity
Christian Kellner et al.
JOURNAL OF IMMUNOLOGY (2012)
Retinoids, Retinoic Acid Receptors, and Cancer
Xiao-Han Tang et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Establishment, Characterization, and Successful Adaptive Therapy Against Human Tumors of NKG Cell, a New Human NK Cell Line
Min Cheng et al.
CELL TRANSPLANTATION (2011)
B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors
Tomonori Kaifu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
Cameron S. Brandt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
The anticancer immune response: indispensable for therapeutic success?
Laurence Zitvogel et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27Kip1
A Dimberg et al.
BLOOD (2002)
Natural killer cells, viruses and cancer
A Cerwenka et al.
NATURE REVIEWS IMMUNOLOGY (2001)
Share Paper
